You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康方生物(09926.HK)與西門子達成合作 加快科技園數字化智能工廠建設
阿思達克 12-10 10:13
康方生物(09926.HK)宣佈,全資子公司康方賽諾醫藥與西門子(中國)簽署商務合同和技術協議,擬提升康方灣區科技園生產體系的自動化、數字化、智能化水平,建設智能工廠,保障高品質抗體新藥生產,進一步提升康方生物整體研發創新和產業化綜合實力。 公司表示,康方灣區科技園位於中山市翠亨新區,總投資超30億元,佔地面積167畝,建築面積44萬平方米,總規劃產能超過10萬升,園區集創新抗體藥物研發、原液及製劑生產、銷售於一體,規劃建設成爲全球技術水平領先的生物醫藥創新研發和產業化基地。康方灣區科技園分三期項目進行建設,項目一期預計2022年投產。 根據協議,西門子將爲康方灣區科技園提供全集成的解決方案,包含SIMATIC PCS 7、Batch等在內的工藝過程自動化系統,並在Batch層面對第三方設備進行集成控制。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account